Half-year report · HY
4570.TEDINET S100X353
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥485m | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥970m | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥444m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥142m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥68m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥150m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥210m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥64m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥150m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥64m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥142m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥249m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥72m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥142m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥72m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥2.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥1.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥310m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥331m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.7bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥955m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥826m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥891m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥771m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥666m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥675m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥174m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥183m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥77m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥38m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥54m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥44m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥15m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥32m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥39m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥15.21 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.74 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.68 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 84.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Cosmeticsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1m |
| Cosmeticsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1m |
| Cosmeticsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥322,000 |
| Immunity Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥484m |
| Immunity Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥484m |
| Immunity Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥142m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥485m |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥485m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥142m |
| Cosmeticsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3m |
| Cosmeticsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3m |
| Cosmeticsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥723,000 |
| Immunity Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥441m |
| Immunity Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥441m |
| Immunity Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥67m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥444m |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥444m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥68m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 421
| Item | Context | Value | Unit |
|---|---|---|---|
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロ－ス市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)清藤 勉 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)群馬県高崎市 | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)株式会社ＳＢＩ証券 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区六本木１丁目６番１号 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)林 ラヒム | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都大田区 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社トランスジェニックグループ | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)福岡県福岡市中央区天神２丁目３番36号 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)楽天証券株式会社 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区南青山２丁目６番21号 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)中沢 祥子 | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都品川区 | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)株式会社東和銀行 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)群馬県前橋市本町２丁目12－６ | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)平田 真悟 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)埼玉県飯能市 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)小野寺 昭子 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)埼玉県越谷市 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)松井証券株式会社 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区麹町１丁目４番地 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)単元株式数100株権利内容に何ら限定のない当社における標準となる株式 | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社免疫生物研究所 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)群馬県藤岡市中字東田1091番地１ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |